Clinical Trial Update: Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer [Phase 3]

View source ↗

Summary

Phase 3 clinical trial of Chiauranib Capsule for Small cell lung cancer has completed. The source does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Chiauranib Capsule (chiauranib)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Small Cell Lung Cancer | Phase 3 | Status: COMPLETED